Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial (Q44483019)

3 December 2017

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial (English)

1 reference

multicenter clinical trial

3 December 2017

1 reference

1 reference

3

1 reference

3 December 2017

Hans-Hellmut Neumayer

9

object named as

Hans-Hellmut Neumayer

1 reference

3 December 2017

Hallvard Holdaas

1

1 reference

3 December 2017

Bengt Fellström

2

1 reference

3 December 2017

Ingar Holme

4

1 reference

3 December 2017

Gudrun Nyberg

5

1 reference

3 December 2017

Per Fauchald

6

1 reference

3 December 2017

Carola Grönhagen-Riska

7

1 reference

3 December 2017

Søren Madsen

8

1 reference

3 December 2017

Edward Cole

10

1 reference

3 December 2017

Bart Maes

11

1 reference

3 December 2017

Patrice Ambühl

12

1 reference

3 December 2017

Anders G Olsson

13

1 reference

3 December 2017

Anders Hartmann

14

1 reference

3 December 2017

Dag O Solbu

15

1 reference

3 December 2017

Terje R Pedersen

16

1 reference

3 December 2017

Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators

17

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

361

1 reference

3 December 2017

2024-2031

1 reference

3 December 2017

9374

1 reference

Premature cardiovascular disease in chronic renal failure

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Impact of serum lipids on long-term graft and patient survival after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Patient survival after renal transplantation III: the effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Cancer incidence in a kidney-transplanted population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Infections in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

1 reference

7 January 2021

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Hyperlipidaemia in renal transplantation--risk factor for long-term graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Cholesterol as an independent predictor of outcome after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Risk for myopathy with statin therapy in high-risk patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913638-0

7 January 2021

10.1016/S0140-6736(03)13638-0

Identifiers

DOI

1 reference

3 December 2017

1 reference